Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
23
Frequently Asked Questions
What is Market Cap of Avalo Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Avalo Therapeutics Inc market cap is $140.14M.
What is the 52-week high for Avalo Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Avalo Therapeutics Inc 52 week high is $16.00 as of September 15, 2025.
What is the 52-week low for Avalo Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Avalo Therapeutics Inc 52 week low is $3.39 as of September 15, 2025.
What is Avalo Therapeutics Inc stock price today?
Avalo Therapeutics Inc stock price today is $10.66.
What was Avalo Therapeutics Inc stock price yesterday?
Avalo Therapeutics Inc stock price yesterday was $10.88.
What is the PE ratio of Avalo Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Avalo Therapeutics Inc’s P/E ratio is -1.14.
What is the Price-to-Book ratio of Avalo Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Avalo Therapeutics Inc P/B ratio is 1.1042.
What is the 50-day moving average of Avalo Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Avalo Therapeutics Inc 50-day moving average is $8.06.
How many employess does Avalo Therapeutics Inc has?